⌘K

Login Start Free

Home/Filings/4/0001064900-23-000002

4//SEC Filing

RIVA SHEPPARD 4

Accession 0001064900-23-000002

CIK 0001016504other

View on SEC.gov Company Profile

Filed

Sep 20, 8:00 PM ET

Accepted

Sep 21, 4:17 PM ET

Size

17.4 KB

Accession

0001064900-23-000002

Insider Transaction Report

Form 4

Period: 2023-05-25

INTEGRATED BIOPHARMA INCINBP

DirectorExecutive Vice President

Transactions

Award
Common Stock
2023-09-20$0.09/sh+50,000$4,500→ 1,273,467 total
Award
Stock Option (right to buy)
2023-05-25+150,000→ 150,000 total(indirect: As Co-Executor of the Estate of E Gerald Kay)
Exercise: $0.23From: 2019-05-24Exp: 2024-03-20→ Common Stock (150,000 underlying)
Award
Stock Option (right to buy)
2023-05-25+66,667→ 66,667 total(indirect: As Co-Executor of the Estate of E Gerald Kay)
Exercise: $0.72From: 2021-11-04Exp: 2024-03-20→ Common Stock (66,667 underlying)
Award
Stock Option (right to buy)
2023-05-25+21,667→ 21,667 total(indirect: As Co-Executor of the Estate of E Gerald Kay)
Exercise: $1.04From: 2022-11-03Exp: 2024-03-20→ Common Stock (21,667 underlying)
Disposition to Issuer
Stock Option (right to buy)
2023-09-20−50,000→ 200,000 total
Exercise: $0.09From: 2015-06-02Exp: 2025-06-02→ Common Stock (50,000 underlying)
Award
Common Stock
2023-05-25$0.40/sh+3,410,512$1,364,205→ 3,426,212 total(indirect: By Trust)

Footnotes (6)

[F1]Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay.
[F2]Closing price of the Issuer's Common Stock on March 20, 2023, date of transfer into the Estate of E Gerald Kay.
[F3]3,410,512 as Co-Executor of the Estate of E Gerald Kay and 15,700 as Trustee to the Emily Sheppard Trust.
[F4]50,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.
[F5]25,000 vested on May 24, 2019 and 41,667 vested each May 24, 2020 and 2021 and 41,666 vested on May 24, 2022.
[F6]33,334 vested on November 4, 2021, the one year anniversary of the grant date and 33,333 vested on November 4, 2022, the second year anniversary of the grant date.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

INTEGRATED BIOPHARMA INC

CIK 0001016504

Entity typeother

Related Parties

1

filerCIK 0001064900

Filing Metadata

Form type: 4
Filed: Sep 20, 8:00 PM ET
Accepted: Sep 21, 4:17 PM ET
Size: 17.4 KB

View on SEC.gov